Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2026 17:14 ET | Source: SkinnyRx

SkinnyRx GLP-1 Claims Evaluated: Review Semaglutide & Tirzepatide Weight Loss Medication Options with Clinician-Guided Care

SkinnyRx compounded semaglutide and tirzepatide GLP-1 program pricing, clinician access, weight loss details, and enrollment terms outlined for 2026.
April 13, 2026 21:11 ET | Source: Vital Step

Vital Step GLP-1 Claims Evaluated: Trusted Doctor-Prescribed GLP-1 Weight Loss Medication with No Hidden Fees

Vital Step offers doctor-prescribed compounded semaglutide and tirzepatide GLP-1 programs online. 2026 overview covers pricing, process, and what to verify
March 17, 2026 19:03 ET | Source: MEDVI

MEDVi GLP-1 Weight Loss Claims Evaluated: 2026 Report Examining "Most Trusted Online Medical Care" Positioning, Telehealth Structure, and Regulatory Context

2026 report evaluates MEDVi's GLP-1 weight loss claims, compounded semaglutide pricing, telehealth structure, and FDA regulatory context.
March 09, 2026 18:48 ET | Source: TrimRx

TrimRx Telehealth Weight Loss Platform Examined in 2026 Consumer Research Report on GLP-1 Medication Access, Pricing Transparency and Safety Considerations

Consumer research report examines TrimRx telehealth GLP-1 programs, compounded semaglutide and tirzepatide pricing, access and safety in 2026
March 09, 2026 18:10 ET | Source: Direct Meds

Direct Meds GLP-1 Program Report 2026: Compounded Semaglutide and Tirzepatide Pricing, Telehealth Access, and Consumer Verification Factors

2026 report on Direct Meds' compounded semaglutide and tirzepatide GLP-1 program, including pricing, telehealth process, and delivery formats.
February 27, 2026 20:57 ET | Source: Breezemeds

BreezeMeds GLP-1 Weight Loss 2026: Compounded Semaglutide and Tirzepatide Pricing (From $199), FDA Regulatory Status Examined

Independent 2026 overview examines BreezeMeds compounded GLP-1 semaglutide telehealth pricing, FDA regulatory status, and what to verify first.
February 26, 2026 18:55 ET | Source: LeanRx, Inc.

SkinnyRx GLP-1 Weight Loss 2026: Compounded Semaglutide and Tirzepatide Program, Pricing, and FDA Regulatory Status Examined

Independent 2026 overview of SkinnyRx compounded semaglutide and tirzepatide GLP-1 weight loss program, pricing, FDA status, and enrollment.
February 25, 2026 20:55 ET | Source: Sprout Health

Sprout Health GLP-1 Weight Loss in 2026 — Compounded Semaglutide Pricing, FDA Status, and What To Know Before Starting a Telehealth GLP-1 Program

Informational overview of Sprout Health's compounded GLP-1 telehealth model, semaglutide and tirzepatide pricing, and FDA status for 2026.
February 24, 2026 21:51 ET | Source: Ivim

Ivim Health GLP-1 Weight Loss Program: Individualized Dosing, Pricing, and What Consumers Should Know in 2026

Ivim Health GLP-1 weight loss program offers compounded semaglutide and tirzepatide with weekly provider check-ins and individualized dosing.
February 05, 2026 19:53 ET | Source: PharmaZee

PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026

PharmaZee telehealth platform information updated. Examining compounded vs FDA-approved GLP-1s amid Novo Nordisk compounding statement Feb 2026.